PW MEDTECH GROUP DL-0001 (PWE) - Total Liabilities
Based on the latest financial reports, PW MEDTECH GROUP DL-0001 (PWE) has total liabilities worth €381.52 Million EUR (≈ $446.04 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PW MEDTECH GROUP DL-0001 liquidity resilience to evaluate the company's liquid asset resilience ratio.
PW MEDTECH GROUP DL-0001 - Total Liabilities Trend (2021–2025)
This chart illustrates how PW MEDTECH GROUP DL-0001's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of PW MEDTECH GROUP DL-0001.
PW MEDTECH GROUP DL-0001 Competitors by Total Liabilities
The table below lists competitors of PW MEDTECH GROUP DL-0001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CONPET SA
RO:COTE
|
Romania | RON136.04 Million |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.00 Billion |
|
Shinhan Seobu T&D REIT Co Ltd
KO:404990
|
Korea | ₩741.43 Billion |
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
Indonesia | Rp261.44 Billion |
|
Major Cineplex Group Public Company Limited
BK:MAJOR
|
Thailand | ฿7.58 Billion |
|
ALM Equity AB Pfd.
ST:ALM-PREF
|
Sweden | Skr1.91 Billion |
|
Koenig & Bauer AG
XETRA:SKB
|
Germany | €1.14 Billion |
|
ABC Taiwan Electronics
TWO:3236
|
Taiwan | NT$1.50 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down PW MEDTECH GROUP DL-0001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See PWE equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PW MEDTECH GROUP DL-0001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PW MEDTECH GROUP DL-0001 (2021–2025)
The table below shows the annual total liabilities of PW MEDTECH GROUP DL-0001 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €381.52 Million ≈ $446.04 Million |
+6.70% |
| 2024-12-31 | €357.56 Million ≈ $418.03 Million |
+9.32% |
| 2023-12-31 | €327.06 Million ≈ $382.37 Million |
-6.97% |
| 2022-12-31 | €351.56 Million ≈ $411.01 Million |
+186.66% |
| 2021-12-31 | €122.64 Million ≈ $143.38 Million |
-- |
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infus… Read more